AMP
At the AMP annual meeting last week, two lab directors shared their experiences and discussed the assay's pros and cons in a company-sponsored workshop.
Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
Premium
The firm is also bringing its comprehensive genomic profiling assay for cancer to the Ion Torrent Genexus sequencing platform in the first half of 2023.
At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.
AMP, CAP Release Guidelines for Use of In Silico Approaches for Validating NGS Data Pipelines
Labs should not let in silico data supplant physical specimens in bioinformatic validation and should understand the limitations of such data.
Lab Orgs Call for CLIA Modernization to Handle LDT Oversight, but CMS Appears to Oppose Idea
Premium
Lab organizations including AMP and AACC have argued CLIA, not the FDA, should oversee LDTs, but a CLIAC official said the FDA should be in charge.
Sep 16, 2022
Aug 25, 2022
Aug 8, 2022